Quantamental Technologies LLC Viking Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.08 - $17.33 $309,189 - $663,149	-38,266 Reduced 79.26%	10,015 $166,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $131,324 - $453,841	48,281 New	48,281 $453,000
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $55,665 - $76,169	-8,725 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$6.55 - $8.6 $17,685 - $23,220	2,700 Added 44.81%	8,725 $60,000
Q2 2019 Aug 12, 2019	BUY	$7.67 - $10.63 $46,211 - $64,045	6,025 New	6,025 $50,000

476

63.4M

5.76M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.5B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.